Status:
RECRUITING
SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients
Lead Sponsor:
Minia University
Conditions:
Glaucoma, Open Angle
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
cyclodiode versus trabeculectomy with MMC in pseudophakic patients.
Detailed Description
Glaucoma is an optic neuropathy that is characterized by progressive structural and functional neuropathy. It is a leading cause of irreversible blindness. Open angle glaucoma (OAG) is the commonest ...
Eligibility Criteria
Inclusion
- 1\. Patients above 40 years old.
- 2\. POAG who underwent previous uncomplicated cataract surgery with intraocular lens implantation.
- 3\. Pseudophakic patients with medically uncontrolled glaucoma in spite of the use of two anti-glaucoma medications or intolerance to medical therapy.
- 4\. Visual field defects in both the superior and inferior hemi-fields outside the central 5 degrees of fixation.
- 5\. Mean deviation on perimetry ranges between -6 dB and -12 dB
Exclusion
- 1\. Patients with history of previous glaucoma surgery. 2. Patients who have used topical steroids within the last three months. 3. Patients with significant media opacity, such as corneal opacity, that obstructs fundoscopic examination.
- 4\. Patients with ocular diseases as uveitis. 5. Patients with severe ocular surface disorders as ocular cicatricial pemphigoid.
- 6\. Aphakic patients. 7. Ocular interventions apart from YAG posterior capsulotomy.
Key Trial Info
Start Date :
July 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07152132
Start Date
July 20 2025
End Date
December 30 2026
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minia University Hospital
Minya, Egypt, 61111